As part of the ABID grant program, CDR is providing access to its recently opened pilot plant for the development of the technologies upcycling dairy byproduct by the selected applicants.
Despite the struggling economy, “the bioreactor/cell culture market remains relatively strong,” claims Mike Sattan, vp of marketing at New Brunswick Scientific (NBS), an Eppendorf company. The ...
Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bioprocess. During scale-up, process ...
As GEN readers are well aware, single-use bioreactors (SUBs)—already accepted at research scale for screening and optimization, as well as at pilot scale and seeding—are now ready for GMP-compliant ...
Over the past 25 years, there has been a steady increase in the sales of biologics, growing at a rate of 12–14% annually. In order cater to this growing demand, over 1,500 commercial scale ...
Fermentation is one of the oldest biotechnologies, yet it’s now driving some of the most cutting-edge innovations in health, nutrition, and sustainability. From therapeutic enzymes and precision ...
Over the past decade, disposable technologies have become a reality in biotech processes. The use of disposables in research and manufacturing allows high flexibility. Over the past decade, disposable ...
Germany’s The Cultivated B. has emerged from stealth mode and has bold plans to enable cellular agriculture at an industrial scale, FoodNavigator hears. The bioreactors currently available to cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results